Cas No.: | 131311-25-6 |
Chemical Name: | 3-bromo-5-((3-oxo-3-((2-((1,2,3,4-tetrahydroisoquinoline-2-carbonyl)oxy)ethyl)amino)propyl)(phenyl)carbamoyl)-1-propylpyridin-1-ium nitrate |
Synonyms: | TCV 309;TCV309 |
SMILES: | O[N+](=O)[O-].CCCN1C(Br)C=C(C=C1)C(=O)N(CCC(=O)NCCOC(=O)N2CC3C(=CC=CC=3)CC2)C4=CC=CC=C4 |
Formula: | C30H34BrN5O7 |
M.Wt: | 656.534 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A highly potent and selective platelet activating factor (PAF) antagonist; inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively; potently protects mice from death induced by PAF and due to anaphylactic shock with ED50 of 2.1 and 2.6 ug/kg (i.v.), respectively; also reverses PAF-induced hypotension and endotoxin-induced hypotension in rats.Coagulation DisorderPhase 2 Discontinued |